(3-Chloro-4-fluorophenyl)(4-fluoro-4-(((2-(pyridazin-4-yloxy)-ethyl)amino)methyl)piperidin-1-yl)methanone

ID: ALA4753988

Chembl Id: CHEMBL4753988

PubChem CID: 132256722

Max Phase: Preclinical

Molecular Formula: C19H21ClF2N4O2

Molecular Weight: 410.85

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(F)c(Cl)c1)N1CCC(F)(CNCCOc2ccnnc2)CC1

Standard InChI:  InChI=1S/C19H21ClF2N4O2/c20-16-11-14(1-2-17(16)21)18(27)26-8-4-19(22,5-9-26)13-23-7-10-28-15-3-6-24-25-12-15/h1-3,6,11-12,23H,4-5,7-10,13H2

Standard InChI Key:  XXKWWMYKJKUXAL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4753988

    ---

Associated Targets(Human)

DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 410.85Molecular Weight (Monoisotopic): 410.1321AlogP: 2.88#Rotatable Bonds: 7
Polar Surface Area: 67.35Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.07CX LogP: 1.23CX LogD: 0.48
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.46

References

1. Sniecikowska J,Gluch-Lutwin M,Bucki A,Więckowska A,Siwek A,Jastrzebska-Wiesek M,Partyka A,Wilczyńska D,Pytka K,Pociecha K,Cios A,Wyska E,Wesołowska A,Pawłowski M,Varney MA,Newman-Tancredi A,Kolaczkowski M.  (2019)  Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT Receptor-Biased Agonists with Robust Antidepressant-like Activity.,  62  (5.0): [PMID:30721053] [10.1021/acs.jmedchem.9b00062]

Source